Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: DaiS who wrote (20901)	4/20/1999 6:49:00 PM
From: VLAD	Read Replies (1) \| Respond to of 23519

DaiS, Because it is considered to be s "supplement" and not a drug. Should be a relatively inexpensive treatment though for men with psychogenic ED and women with psychogenic sexual dysfunction. Just another vulture company trying to capitalize on the ED/SD hype/frenzy. Only in America!

To: DaiS who wrote (20901)	4/20/1999 6:52:00 PM
From: Edderd	Read Replies (1) \| Respond to of 23519

DaiS They can claim any thing they want because there are no standards. If they can get a few "patients" to change their testosterone levels then they can use them as testamonials. The testosterone test is notoriously inaccurate (usual normal range 200 to 1000) so a normal variation could be called the result of the treatment. Used all the time in so called "alternative medicine". So what! In the long run they never work and the "patients" look for another "cure". Always been with us and always will be. The public is (are?)not a scientist. If you can get the public to use a product that works then the word spreads. That is our problem. Ed